CymitQuimica logo
PI3K/Akt/mTOR Signaling

PI3K/Akt/mTOR Signaling

PI3K/Akt/mTOR signaling inhibitors are compounds that target the phosphoinositide 3-kinase (PI3K), Akt kinase, and mammalian target of rapamycin (mTOR) pathways. These pathways are critical regulators of cell growth, survival, metabolism, and autophagy, making them key targets in cancer research and metabolic disorders. Inhibiting these pathways can help to control tumor growth and proliferation, offering potential therapeutic strategies for various cancers and other diseases characterized by dysregulated cell signaling. At CymitQuimica, we offer a comprehensive selection of high-quality PI3K/Akt/mTOR inhibitors to support your research in oncology, cellular signaling, and metabolic diseases.

Subcategories of "PI3K/Akt/mTOR Signaling"

Show 2 more subcategories

Found 993 products of "PI3K/Akt/mTOR Signaling"

Sort by

Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
products per page.
  • Petosemtamab

    CAS:

    Petosemtamab (MCLA 158), a dual-action monoclonal antibody targets EGFR & LGR5, used in solid tumor research like HNSCC & CRC.

    Purity:> 95% - > 95%
    Color and Shape:Liquid
    Molecular weight:145.97 kDa

    Ref: TM-T76890

    1mg
    338.00€
    5mg
    882.00€
    10mg
    1,415.00€
  • DSPE-PEG1000-GE11


    DSPE-PEG1000-GE11 is a PEG compound made up of DSPE and an EGFR-targeting peptide (GE11). GE11 is applicable for cancer cells overexpressing EGFR. DSPE-PEG1000-GE11 serves a role in drug delivery.
    Color and Shape:Odour Solid

    Ref: TM-TCL-01150

    10mg
    To inquire
    50mg
    To inquire
  • mTOR inhibitor WYE-28

    CAS:
    mTOR inhibitor WYE-28, Potent mTOR (IC50=0.08 nM) and PI3Kα (IC50=6 nM) inhibitor, short half-life in mouse microsomes.
    Formula:C30H34N8O5
    Purity:98.13%
    Color and Shape:Solid
    Molecular weight:586.65

    Ref: TM-T36307

    1mg
    88.00€
    5mg
    268.00€
    10mg
    447.00€
    25mg
    893.00€
    50mg
    1,198.00€
    100mg
    1,603.00€
  • MS9427 TFA


    MS9427 TFA: PROTAC EGFR degrader, Kd 7.1 nM (WT), 4.3 nM (L858R), targets mutant EGFR, inhibits NSCLC cell growth, for cancer research.
    Formula:C50H59ClF4N8O14
    Color and Shape:Solid
    Molecular weight:1107.5

    Ref: TM-T74634

    5mg
    To inquire
    50mg
    To inquire
  • GSK-3β inhibitor 23


    GSK-3β inhibitor23 (Compound 11726169) is an inhibitor of glycogen synthase kinase 3 (GSK-3), effectively inhibiting GSK-3β and GSK-3α with IC50 values of 12.1 nM and 18.8 nM, respectively. It demonstrates antiviral activity against HIV1 and exhibits good metabolic stability in mouse and human liver microsomes and plasma, although it has poor permeability in Caco-2 cells, indicating potentially low oral bioavailability.
    Formula:C18H13Cl2N5O2S
    Color and Shape:Solid
    Molecular weight:434.299

    Ref: TM-T204398

    10mg
    To inquire
    50mg
    To inquire
  • EGFR-TK-IN-5


    EGFR-TK-IN-5 (Compound NCE 2) is a thiazolyl pyrazoline derivative with significant inhibitory activity and stability against EGFR. It is applicable in tumor research.
    Formula:C26H20ClFN4OS
    Color and Shape:Solid
    Molecular weight:490.98

    Ref: TM-T205705

    10mg
    To inquire
    50mg
    To inquire
  • QL-IX-55

    CAS:
    QL-IX-55 has a wide range of applications in life science related research.
    Formula:C24H14F4N4O
    Color and Shape:Solid
    Molecular weight:450.39

    Ref: TM-T36313

    25mg
    1,369.00€
  • Simotinib hydrochloride

    CAS:
    Simotinib hydrochloride: selective oral EGFR inhibitor, IC50 19.9 nM, potent anticancer agent.
    Formula:C25H27Cl2FN4O4
    Color and Shape:Solid
    Molecular weight:537.41

    Ref: TM-T39019

    5mg
    873.00€
  • RMC-4529

    CAS:
    RMC-4529 is a chemical compound that demonstrates potent inhibition, with an IC50 value of 1.0 nM, against p-4E-BP1-(T37/46) in mTOR kinase cellular assays.
    Formula:C90H139N13O23
    Color and Shape:Solid
    Molecular weight:1771.17

    Ref: TM-T39776

    5mg
    To inquire
  • Tephrosin

    CAS:
    Tephrosin induces degradation of of EGFR and ErbB2 by inducing internalization of the receptors, has potent antitumor activities.
    Formula:C23H22O7
    Purity:98%
    Color and Shape:Solid
    Molecular weight:410.42

    Ref: TM-T13126

    5mg
    882.00€
  • HER2/neu (654-662) GP2

    CAS:
    Phage display selected Affibody ligands for HER2/neu from a protein library based on a 58-residue Staphylococcal protein A Z domain.
    Formula:C42H77N9O11
    Purity:98%
    Color and Shape:Solid
    Molecular weight:884.11

    Ref: TM-TP1583

    100mg
    To inquire
    500mg
    To inquire
  • IBI-334


    IBI-334 is a bispecific antibody targeting both B7-H3 and EGFR. It features an EGFR arm responsible for signal blocking, connected to a modified B7-H3 arm that ensures optimal affinity and binding. The antibody is afucosylated to enhance its antibody-dependent cellular cytotoxicity (ADCC) effects. IBI-334 is widely applicable in EGFR-driven solid tumors.
    Color and Shape:Odour Liquid

    Ref: TM-T9901A-802

    1mg
    To inquire
    5mg
    To inquire
  • Anticancer agent 271


    Anticanceragent 271 (compound 5C) exhibits antiproliferative activity against lung cancer (A549), colon cancer (Caco-2) cell lines, and human lung fibroblasts (WI38), with an IC50 value of 9.18 μM for A549 cells. This compound can downregulate PI3K and mTOR gene expression and is applicable in cancer research.
    Color and Shape:Odour Solid

    Ref: TM-T206744

    10mg
    To inquire
    50mg
    To inquire
  • Varlitinib Tosylate

    CAS:
    Varlitinib Tosylate is a selective and potent inhibitor of ErbB1(EGFR) and ErbB2(HER2).
    Formula:C36H35ClN6O8S3
    Purity:98%
    Color and Shape:Solid
    Molecular weight:811.34

    Ref: TM-T20954

    25mg
    1,369.00€
  • Multi-target kinase inhibitor 4


    Multi-target kinase inhibitor 4 (Compound 2) is a PI3K/DNA-PK inhibitor and a potent chemosensitizer that enhances the number of DNA double-strand breaks induced by Doxorubicin. It serves as an effective multidrug resistance (MDR) inhibitor, demonstrating inhibitory activity against P-glycoprotein (P-gp) mediated drug efflux. Multi-target kinase inhibitor 4 can be encapsulated in PEG-coated lipid nanoparticles.
    Color and Shape:Odour Solid

    Ref: TM-T206635

    10mg
    To inquire
    50mg
    To inquire
  • PI3Kα-IN-25


    PI3Kα-IN-25 (Compound Djh1) is a selective inhibitor of PI3Kα, suitable for research in triple-negative breast cancer.
    Formula:C21H19ClN4O4
    Color and Shape:Solid
    Molecular weight:426.853

    Ref: TM-T205675

    10mg
    To inquire
    50mg
    To inquire
  • AMX-818


    AMX-818 is a conditionally activated, masked T cell engager (TCE) that targets HER2. It demonstrates potent T cell cytotoxicity against HER2-positive tumor cell lines and can induce tumor regression in vivo. AMX-818 holds promise for research into HER2-positive solid tumors.
    Color and Shape:Odour Liquid

    Ref: TM-T9901A-962

    1mg
    To inquire
    5mg
    To inquire
  • Varlitinib

    CAS:
    Varlitinib (ASLAN001) is a potent, reversible, small molecule pan-EGFR inhibitor with IC50s of 7, 2, 4 nM for HER1, HER2 and HER4, respectively.
    Formula:C22H19ClN6O2S
    Purity:99.7%
    Color and Shape:Solid
    Molecular weight:466.94

    Ref: TM-T6719

    1mg
    34.00€
    5mg
    60.00€
    10mg
    96.00€
    25mg
    161.00€
    50mg
    To inquire
    1mL*10mM (DMSO)
    70.00€
  • Lyso-Monosialoganglioside GM3

    CAS:
    Lyso-Monosialoganglioside GM3 (Lyso-GM3) is an analog of Ganglioside GM3 with antitumor properties. It inhibits the increase in EGFR kinase activity induced by EGF in A431 epithelial cancer cells.
    Formula:C41H74N2O20
    Color and Shape:Solid
    Molecular weight:915.028

    Ref: TM-T206584

    10mg
    To inquire
    50mg
    To inquire
  • EGFR-IN-124


    EGFR-IN-124 (compound 10A) is an EGFR inhibitor with an IC50 value of 0.54 μM, utilized in cancer research.
    Color and Shape:Odour Solid

    Ref: TM-T200720

    10mg
    To inquire
    50mg
    To inquire